Associated organisationsKing's College London · University College LondonEurope PMC affiliations are not treated as award recipients or mapped locations.
Funding£4.6M
PeriodJun 2019 — Oct 2023
In plain English
AI plain-English summary
A brain scan today captures a wealth of detail that is largely ignored in clinical decisions. The Programme for High-Dimensional Translation in Neurology, led by Parashkev Nachev at University College London, will build regulatory-approved computer systems that combine MRI and CT scans with comprehensive clinical records to predict individual patient outcomes in neurology. Current medical practice typically reduces complex brain data to a handful of simple measurements, missing the multifactorial mechanisms that cause neurological disease. Without modelling the brain in its full complexity, clinicians cannot deliver truly personalised medicine. This programme addresses that gap by creating a replicable blueprint for embedding high-dimensional analysis into established clinical pathways with minimal disruption to existing workflows. If successful, the system will support decision-making at two levels: for individual clinicians treating patients, and for institutions managing operational resources. The team will focus on stroke, neuroradiology, and acute cognitive dysfunction—areas with the greatest population-level significance. Working with healthcare and enterprise partners, the programme aims for near- to medium-term impact, while the model weights on each factor will also illuminate the complex mechanisms driving disease.
View original technical description
To accelerate translation in neurology we must begin to model the brain in its full complexity. Without such high-dimensional modelling, we cannot understand the multifactorial mechanisms of disease causation, nor deliver individualised personalised medicine Innovating across several administrative, clinical, scientific, and technological domains, the Programme for High-Dimensional Translation in Neurology, headed by Parashkev Nachev at University College London, will a build high-dimensional, regulatorily-approved decision systems that predict clinical outcome and thereby support decision making at the individual, clinical level, and at the institutional, operational level. The team will do this by combining the richest source of structural information about the brain-magnetic resonance (MR) and computed tomography (CT) imaging-with comprehensive clinical data and create a replicable blueprint for embedding this approach within healthcare. The aim is to integrate the use of multidimensional data in this way into established ciinicai pathways in order to derive vaiue with minimai change to clinical practice. This will accelerate adoption and allow the benefits of such a system to be more easily achieved. Working in tandem with healthcare and enterprise partners, the Programme will focus on near to medium term goals, delivering real-world impact addressed to defined operational, clinical, and scientific objectives, within areas of neurology with greatest population-level significance. Additionally, the model weights on each factor will illuminate complex mechanisms of disease. We shall focus on a set of interlocking investigational and disease-specific areas: stroke, neuroradiology, and acute cognitive dysfunction in acute medicine.
Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.
Is something wrong? Let us know